Boston Scientific's new OPAL HDx three-dimensional marking measurement system has officially been approved in China.

On March 6th, it was learned from Boston Scientific Corporation that the company's new OPAL HDx cardiac electrophysiology three-dimensional mapping system has officially obtained approval from the National Medical Products Administration. This system is equipped with the FARAVIEW software module, which allows doctors to visualize three-dimensional mapping and ablation results. It can also be used in conjunction with the FARAWAVE NAV disposable magnetic catheter with added magnetic positioning function to achieve three-dimensional cardiac mapping functionality.